|
South San Francisco, CA, February 7, 2003 — Telik,
Inc. (Nasdaq: TELK) announced that its quarterly conference call
and webcast has been scheduled for Thursday, February 13, 2003 at
4:30 p.m. Eastern time. The call will follow the release of Telik's
fourth quarter 2002 financial results after the close of the financial
markets on February 13, 2003.
Participants may access the live webcast via Telik's website at
www.telik.com or by telephone at (612) 332-0228. A replay of the
webcast will be available on the Telik website from approximately
8:30 p.m. Eastern time on February 13 through February 20, 2003.
About Telik
Telik, Inc. of South San Francisco, CA is a biopharmaceutical company
working to discover, develop and commercialize small molecule drugs
to treat serious diseases for which there is significant demand
for new therapies. The company's most advanced drug development
candidate is TLK286, a tumor activated small molecule drug that
is in Phase 2 clinical trials in ovarian, non-small cell lung, colorectal
and breast cancer. Telik's product candidates were discovered using
its proprietary drug discovery technology, TRAP, which enables the
rapid and efficient discovery of small molecule drug candidates.
Additional information is available at www.telik.com.
You should not rely on forward-looking statements contained in
this press release. Telik can give no assurance with regard to these
statements, as they are subject to various risks and uncertainties.
All of Telik's product candidates, including TLK286, are in the
early stages of development, and the potential benefits of each
must still be proven. More detailed information regarding factors
that may cause actual results to differ materially from the results
expressed or implied by statements in this press release may be
found in Telik's periodic filings with the Securities and Exchange
Commission. Telik assumes no obligation to update any information
in this press release.
###
Contact:
Carol DeGuzman
Senior Director, Corporate Communications
Telik, Inc.
Tel 650-845-7728
Email cdeguzman@telik.com
Go to: 2003
Press Releases2004
Press ReleasesEvents
|
